Patent ID: 9387178
Filing Date: 2016-07-12
CPC Classification: A61K,A61P

Claim Text:
1. A modified release dosage form comprising: (A) a compressed matrix core which comprises: (B) a functional coating on said compressed matrix core which comprises wherein the dosage form, exhibits the following dissolution profile when tested in a USP Type 2 (paddle) apparatus at 50 RPM in 900 ml of 0.1 N HCl at 37° C.: after 15 minutes 10-50% of the tranexamic acid is released; after 30 minutes 40-95% of the tranexamic acid is released; after 45 minutes 50-99% of the tranexamic acid is released; and after 60 minutes, not less than 70% of the tranexamic acid is released.